AML Samples Show High Concordance in Detection of Mutations by NGS at Local Institutions versus Central Laboratories

By sjmartinez • July 18, 2023

Borate U, Yang F, Press RD, Ruppert AS, Jones D, Caruthers S, Zhao W, Vergilio JA, Pavlick D, Juckett L, Norris BA, Bucy T, Burd A, Stein EM, Patel PA, Baer MR, Stock W, Schiller GJ, Blum W, Kovacsovics TJ, Litzow MR, Foran JM, Heerema NA, Rosenberg L, Marcus S, Yocum AO, Stefanos M, Druker BJ, Mims AS. AML Samples Show High Concordance in Detection of Mutations by NGS at Local Institutions versus Central Laboratories. Blood Adv. 2023 Jul 17:bloodadvances.2022009008. doi: 10.1182/bloodadvances.2022009008. Epub ahead of print. PMID: 37459200.

Tags: Hematology/Oncology, Publications

Lentivirus-Based Hematopoietic Stem/Progenitor Cell Therapy Provides Effective and Long-Term Treatment in Hypophosphatasia Mouse Model

Carrillo M, Tomer S, Wang L, Cook E, Wennerberg W, Tien N, Ng H, Alagarsamy J, Rezek V, Martin H, Narisawa S, Millan JL, Crine[...]

Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival

Marsh LA, Kim TH, Zhang M, Kubalanza K, Treece CL, Chase D, Memarzadeh S, Salani R, Karlan B, Rao J, Konecny GE. Pathologic response to[...]

Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care

Brufsky AM, Finn RS, Metzger O, Goncalves R, Huang-Bartlett C, Sreenivasan S, Nur U, Davies J, Grigorenko A, Long GH. Comparative effectiveness of CDK4/6 inhibitors[...]